Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -48.80% is in line with its 3-year average of -47.74%, near the high end of its 3-year range (-81.19%–-35.21%).
4.49% above its 12-month average of -51.10%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -51.84%.
EBITDA MARGIN
-48.80%
EBITDA MARGIN AVG TTM
-51.10%
EBITDA MARGIN AVG 3Y
-47.02%
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+4.49%
CURRENT VS 3Y AVG
-3.77%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Shoulder Innovations, Inc.
Market Cap
$376.61M
EBITDA Margin
-48.80%
TTM Avg
-51.10%
3Y Avg
-47.02%
5Y Avg
N/A
Market Cap
$1.14B
EBITDA Margin
3.96%
TTM Avg
-13.21%
3Y Avg
-146.19%
5Y Avg
-104.68%
Market Cap
$2.99B
EBITDA Margin
22.42%
TTM Avg
17.70%
3Y Avg
-0.76%
5Y Avg
-37.34%
Market Cap
$5.10B
EBITDA Margin
21.06%
TTM Avg
20.50%
3Y Avg
18.63%
5Y Avg
16.67%
Market Cap
$5.59B
EBITDA Margin
-395.82%
TTM Avg
-536.17%
3Y Avg
-471.62%
5Y Avg
-471.62%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $376.61M | -48.80% | -51.10% | -47.02% | N/A |
| NRC Health (NRC)vs › | $463.35M | 21.99% | 25.40% | 28.98% | 31.97% |
| PDS Biotechnology Corporation (PDSB)vs › | $45.05M | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.14B | 3.96% | -13.21% | -146.19% | -104.68% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.91B | 16.41% | 1.22% | -1.65% | 4.31% |
| TransMedics Group, Inc. (TMDX)vs › | $2.99B | 22.42% | 17.70% | -0.76% | -37.34% |
| Doximity, Inc. (DOCS)vs › | $4.88B | 35.56% | 38.69% | 36.58% | 34.55% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 21.06% | 20.50% | 18.63% | 16.67% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.59B | -395.82% | -536.17% | -471.62% | -471.62% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | 6.82% | 6.08% | -0.44% | -8.67% |
Gross Margin
77.3%
EBITDA Margin
-48.8%
Operating Margin
-58.5%
Net Margin
-58.3%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -51.84% |
| 2026-03-31 | -46.95% |
| 2025-12-31 | -52.16% |
| 2025-09-30 | -57.83% |
| 2025-06-30 | -46.71% |
| 2025-03-31 | -35.79% |
| 2024-12-31 | -40.53% |
| 2024-09-30 | -52.08% |
| 2024-06-30 | -41.95% |
| 2024-03-31 | -38.39% |
| 2023-12-31 | -35.21% |
| 2023-09-30 | -81.19% |
| 2023-06-30 | -64.87% |
| 2023-03-31 | -56.30% |
